ESTROGEN-RECEPTOR IN BREAST-CANCER - PROGNOSTIC STUDIES USING A NEW IMMUNOHISTOCHEMICAL ASSAY

被引:20
作者
COWEN, PN [1 ]
TEASDALE, J [1 ]
JACKSON, P [1 ]
REID, BJ [1 ]
机构
[1] COOKRIDGE HOSP,YRCO,LEEDS LS16 6QB,W YORKSHIRE,ENGLAND
关键词
breast; cancer; oestrogen receptor; prognostic factors;
D O I
10.1111/j.1365-2559.1990.tb00735.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A recently developed and validated histochemical method—immunogold–streptavidin enhancement—was used to determine oestrogen receptor content in paraffin sections of breast cancers. The selection of the best cut‐off point to define oestrogen receptor status as rich or poor was made on the basis of survival data, using the following indices: survival to term; disease‐free interval; survival at 5 years; and disease‐free interval at 5 years. Oestrogen receptor status was examined in relation to histological grade, lymph node status, menopausal status and tumour size and these four indices were considered as independent prognostic factors. Semi‐quantitative assay of receptor content showed that increasing content was related to better prognosis. Adjuvant therapy alone had no effect on patient outcome. Independently, histological grade and lymph node status, but not menopausal status or tumour size, were prognostic indicators. Oestrogen receptor rich status, as measured by immunogold–streptavidin, in conjunction with certain of these factors indicated a better prognosis. This was comparable with results in reports using other methods of receptor assay. We found the oestrogen receptor status and menopausal status more significant at 5 years than at term. The advantage of immunogold–streptavidin enhancement, which we found as reliable as other methods for oestrogen receptor assay, is that it can be used on archival, routinely paraffin‐processed material. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:319 / 325
页数:7
相关论文
共 25 条
[1]   RELATION BETWEEN ESTROGEN-RECEPTOR CONCENTRATION AND CLINICAL AND HISTOLOGICAL FACTORS - THEIR RELATIVE PROGNOSTIC IMPORTANCE AFTER RADICAL-MASTECTOMY FOR PRIMARY BREAST-CANCER [J].
ANDRY, G ;
SUCIU, S ;
PRATOLA, D ;
SYLVESTER, R ;
LECLERCQ, G ;
DACOSTA, PM ;
LEGROS, N ;
ANDRYTHOOFT, M ;
VERHEST, A ;
MATTHEIEM, W ;
HEUSON, JC .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02) :319-329
[2]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[3]   THE INFLUENCE OF HORMONE RECEPTORS AND HORMONAL ADJUVANT THERAPY ON DISEASE-FREE SURVIVAL IN BREAST-CANCER - A MULTIFACTORIAL ANALYSIS [J].
CALDAROLA, L ;
VOLTERRANI, P ;
CALDAROLA, B ;
LAI, M ;
JAYME, A ;
GAGLIA, P .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (02) :151-155
[4]   ESTROGEN-RECEPTORS AND SURVIVAL IN EARLY BREAST-CANCER [J].
CROTON, R ;
COOKE, T ;
HOLT, S ;
GEORGE, WD ;
NICOLSON, R ;
GRIFFITHS, K .
BMJ-BRITISH MEDICAL JOURNAL, 1981, 283 (6302) :1289-1291
[5]  
HAHNEL R, 1979, CANCER, V44, P671, DOI 10.1002/1097-0142(197908)44:2<671::AID-CNCR2820440238>3.0.CO
[6]  
2-V
[7]   SURFACE-MEMBRANE STAINING OF IMMUNOGLOBULINS IN PARAFFIN SECTIONS OF NON-HODGKINS LYMPHOMAS USING IMMUNOGOLD-SILVER STAINING TECHNIQUE [J].
HOLGATE, CS ;
JACKSON, P ;
LAUDER, I ;
COWEN, PN ;
BIRD, CC .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (07) :742-746
[8]   IMMUNOGOLD SILVER STAINING - NEW METHOD OF IMMUNOSTAINING WITH ENHANCED SENSITIVITY [J].
HOLGATE, CS ;
JACKSON, P ;
COWEN, PN ;
BIRD, CC .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1983, 31 (07) :938-944
[9]   THE EFFECT OF ESTROGEN AND PROGESTERONE RECEPTORS ON RECURRENCE AND SURVIVAL IN PATIENTS WITH CARCINOMA OF THE BREAST [J].
HOWAT, JMT ;
HARRIS, M ;
SWINDELL, R ;
BARNES, DM .
BRITISH JOURNAL OF CANCER, 1985, 51 (02) :263-270
[10]  
HOWELL A, 1984, LANCET, V1, P588